Dr. Fishkin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8940 N Wood Sage Rd
Peoria, IL 61615Phone+1 309-243-3000Fax+1 309-243-3050
Education & Training
- Letterman Army Medical CenterFellowship, Hematology and Medical Oncology, 1987 - 1990
- University of Oklahoma Health Sciences CenterResidency, Internal Medicine, 1984 - 1987
- Creighton University School of MedicineClass of 1984
- Creighton UniversityB.A., 1980
Certifications & Licensure
- IL State Medical License 1993 - 2026
- CA State Medical License 1988 - 2025
- HI State Medical License 1990 - 2008
- OK State Medical License 1985 - 1991
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013
Clinical Trials
- Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma Start of enrollment: 2010 Apr 15
- Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer Start of enrollment: 2010 Sep 09
- Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas Start of enrollment: 2014 Jul 29
- Join now to see all
Publications & Presentations
PubMed
- 100 citationsFulvestrant in Women With Advanced Breast Cancer After Progression on Prior Aromatase Inhibitor Therapy: North Central Cancer Treatment Group Trial N0032James N. Ingle, Vera J. Suman, Kendrith M. Rowland, Deepu Mirchandani, Albert M. Bernath
Journal of Clinical Oncology. 2006-03-01 - 22 citationsPhase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomas.Ajay Major, Justin Kline, Theodore Karrison, Paul A. S. Fishkin, Amy S. Kimball
Haematologica. 2021-07-29 - 120 citationsPulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic...Alexa B. Schrock, Shuyu D. Li, Garrett M. Frampton, James Suh, Eduardo Braun
Journal of Thoracic Oncology. 2017-06-01
Journal Articles
- Phase II interventional study (N0337) of capecitabine in combination with vinorelbine and trastuzumab for first- or second-line treatment of HER2-positive metastatic b...Tan WW, Allred JB, Salim M, Flynn P, Fishkin PA, Stella PJ, Wiesenfeld M, Bernath AM, Fitch TR, Perez EA, Clin Breast Cancer, 1/1/2012
- CD10 Detection by Flow Cytometry as a Prognostic Marker in de Novo Diffuse Large B-Cell LymphomaSiebert JD, Weeks LM, Sun J, Knost JA, Fishkin PAS, Thomas SP, Kugler JW, Am J Clin Path, 1/1/2002
- Utility of flow cytometry immunophenotyping of fine needle aspiration/biopsy samples in the diagnosis and classification of lymphoma in a community hospitalSiebert JD, Weeks LM, List LW, Kugler JW, Knost JA, Fishkin PAS, Goergen MH, Am J Clin Pathol, 1/1/1999
- Join now to see all
Abstracts/Posters
- Evaluation of chemotherapy within last two weeks of life: Patterns of careThomas SP, Rice MA, Ho TA, Heard B, Harper J, Fishkin PAS, ASCO Annual Meeting; J Clin Oncol, 1/1/2013
- Phase I Trial of Rituximab, Cladribine and Temsirolimus (RCT) for Initial Therapy of Mantle Cell LymphomaInwards DJ, Fishkin, P, LaPlant BR, Drake MT, Kurtin P, Nikcevich D, Wender D, Lair B, Witzig TE, ASH Annual Meeting, 1/1/2012
- Phase II Study of Rituximab and Cladribine (2-CDA) in Newly Diagnosed Mantle Cell Lymphoma (N0189)Inwards DJ, Hillman DW, Fishkin PA, White WL, Morton RF, Dakhil SR, Nikcevich DA, Wender DB, Fitch RT, Kurtin PJ:, Proc Annu Meet Am Soc Clin Oncol, 1/1/2006
- Join now to see all
Lectures
- Clinical Careers in Hematology (Private Practice Careers)61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Career-Development Lunch Sessions: Clinical Careers in Hematology (Private Practice)60th American Society of Hematology Annual Meeting - 12/1/2018
- “Onco-Genetics of Cancer” SeminarUniversity of Illinois College of Medicine, Peoria, IL - 1/16/1998
- Join now to see all
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: